Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Jul, 24 2025
Oct, 3 2025
Sep, 23 2025
Oct, 6 2025
May, 4 2026